D
Axsome Therapeutics, Inc. AXSM
$121.91 $0.260.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -287.22M -310.96M -308.55M -296.38M -239.24M
Total Depreciation and Amortization 7.96M 7.63M 7.31M 7.00M 6.83M
Total Amortization of Deferred Charges 2.64M 2.39M 2.34M 2.61M 2.57M
Total Other Non-Cash Items 114.31M 143.85M 120.88M 119.61M 113.14M
Change in Net Operating Assets 33.90M 24.53M 10.54M -25.57M -28.39M
Cash from Operations -128.41M -132.57M -167.49M -192.73M -145.08M
Capital Expenditure -270.00K -247.00K -528.00K -609.00K -582.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -270.00K -247.00K -528.00K -609.00K -582.00K
Total Debt Issued -- 0.00 0.00 30.00M 85.00M
Total Debt Repaid -990.00K -660.00K -349.00K -163.00K --
Issuance of Common Stock 71.46M 55.04M 59.72M 273.28M 271.17M
Repurchase of Common Stock -3.95M -3.70M -3.58M -2.59M -1.84M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -8.68M -7.09M -9.23M -22.27M -23.32M
Cash from Financing 57.84M 43.59M 46.56M 278.26M 331.01M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -70.84M -89.22M -121.46M 84.93M 185.35M
Weiss Ratings